Chemotherapy induced peripheral neuropathy: The modified total neuropathy score in clinical practice

Irish Journal of Medical Science

Volumn 183, Issue 1, 2014, Pages 53-58

  Vasquez, S ^a   Guidon, M ^b   McHugh, E ^b   Lennon, O ^b   Grogan, L ^a   Breathnach, O S ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Chemotherapy; Function; Neurotoxic; Peripheral neuropathy; Physiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; NAVELBINE; OXALIPLATIN; PACLITAXEL; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BERG BALANCE SCALE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; MALE; PERIPHERAL NEUROPATHY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; BODY EQUILIBRIUM; CHEMICALLY INDUCED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECTS; IRELAND; MIDDLE AGED; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; POSTURAL BALANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84893731966     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-013-0971-5     Document Type: Article

References (19)

1. Postma TJ, Heimans JJ, Muller MJ et al (1998) Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9:739-744 (Pubitemid 28394160)
2. Visovsky C (2003) Chemotherapy-induced peripheral neuropathy. Cancer Invest 21(3):439-445 (Pubitemid 37059093)
3. Dunlap B, Paice JA (2006) Chemotherapy-induced peripheral neuropathy: a need for standardization in measurement. J Support Oncol 4(8):398-399 (Pubitemid 44541015)
4. Visovsky C, Daly B (2004) Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract 16(8):353-359 (PMID: 15455708)
5. Wampler MA, Miaskowski C, Hamel K et al (2006) The modified total neuropathy score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. J Support Oncol 4(8):W9-W16
6. Lavoie Smith E, Beck S, Cohen J (2010) The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs 33(3):173-183
7. Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practise: evidence-based interventions for chemotherapy-induced peripheral neuropathy. CJON 11(6):901-913
8. Chaudhry V, Rowinsky E, Sartorius S et al (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35(3):304-311 (Pubitemid 24089653)
9. Fuller G (2004) Neurological examination made easy, 3rd edn. Churchill Livingstone, England
10. Shumway-Cook A, Braver S, Woollacott M (2000) Predicting the probability for falls in community-dwelling older adults using the timed up and go test. Phys Ther 80(9):896-903
11. Ng S, Hui-Chan CW (2005) The timed up and go test: its reliability and association with lower limb impairments and locomotor capacities in people with chronic stroke. Arch Phys Med Rehabil 86(6):1641-1647 (Pubitemid 41115829)
12. La Porto F, Caselli S, Susassi S et al (2012) Is the Berg Balance Scale an internally valid and reliable measure of balance across different aetiologies in neurorehabilitation? A revisited Rasch analysis study. Arch Phys Med Rehabil 93(7):1209-1216
13. King M, Stockler M, Cella D et al (2010) Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G. J Clin Epidemiol 63:270-281
14. Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications and interpretation. Health Qual Life Outcomes 1:79 (Pubitemid 39111917)
15. Shumway-Cook A, Baldwin M, Nayak L et al (1997) Predicting the probability for falls in community-dwelling older adults. Phys Ther 77:812-819 (Pubitemid 27332973)
16. Carr JH, Shepherd RB (1998) Neurological rehabilitation: optimising motor performance. Butterworth-Heinemann, Oxford, UK
17. Argyriou AA, Polychronopoulos P, Koutras A et al (2006) Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer 14(3):223-229 (Pubitemid 43247926)
18. Bakitas M (2007) Background noise - the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323-331
19. Lavoie Smith E, Cohen J, Pett M et al (2008) The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 35(1):96-102